QNTM 6-K: SEC filing
Filed with the SEC on · accession 0001185185-26-005323
QNTM filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved -8.2% by the first close after the filing.
Summary of the filing
Quantum Biopharma Ltd. furnished its quarterly interim financial statements and management's discussion and analysis for the three and nine months ended September 30, 2026 and 2025 on Form 6-K.
Key details
How QNTM stock reacted
Close before
$1.94
Nov 11, 2026
First close after
-8.25%
$1.78
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for QNTM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for QNTM?
Click hereFrequently asked questions
What did QNTM file with the SEC on Nov 12, 2026?
QNTM filed a 6-K (SEC filing). Quantum Biopharma Ltd. furnished its quarterly interim financial statements and management's discussion and analysis for the three and nine months ended September 30, 2026 and 2025 on Form 6-K.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did QNTM stock react to this filing?
QNTM closed at $1.94 before the filing and $1.78 on Nov 12, 2026 (-8.25%).
Other QNTM SEC filings
Get alerts when QNTM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days